Arkema SA (OTCMKTS:ARKAY) Short Interest Update

Arkema SA (OTCMKTS:ARKAYGet Free Report) was the target of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 7 shares, a drop of 99.3% from the January 15th total of 1,065 shares. Based on an average trading volume of 21,622 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 21,622 shares, the days-to-cover ratio is presently 0.0 days.

Arkema Stock Up 10.4%

Shares of ARKAY traded up $7.33 during midday trading on Tuesday, hitting $77.45. The stock had a trading volume of 5,379 shares, compared to its average volume of 7,954. The firm has a market cap of $5.89 billion, a price-to-earnings ratio of 37.24, a price-to-earnings-growth ratio of 1.38 and a beta of 0.90. The company has a 50 day simple moving average of $61.26 and a two-hundred day simple moving average of $63.67. Arkema has a twelve month low of $56.28 and a twelve month high of $91.51. The company has a debt-to-equity ratio of 0.55, a current ratio of 3.07 and a quick ratio of 2.26.

Arkema (OTCMKTS:ARKAYGet Free Report) last posted its quarterly earnings data on Friday, November 7th. The basic materials company reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.21. Arkema had a return on equity of 5.15% and a net margin of 1.55%.The business had revenue of $2.52 billion during the quarter, compared to the consensus estimate of $2.50 billion. On average, analysts anticipate that Arkema will post 8.36 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ARKAY shares. Deutsche Bank Aktiengesellschaft cut shares of Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. Zacks Research cut Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Finally, The Goldman Sachs Group raised Arkema from a “neutral” rating to a “buy” rating in a research report on Tuesday. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce”.

Read Our Latest Research Report on ARKAY

About Arkema

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

See Also

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.